New study reveals oral markers may predict COVID-19 disease course

Medical News: A groundbreaking study conducted by researchers from the University of North Carolina at Chapel Hill (UNC)-USA, has unveiled that oral responses to SARS-CoV-2 could play a key role in predicting the early progression of COVID-19. The study focuses on oral biomarkers as a non-invasive, early indicator of the disease. By analyzing the presence of the virus and related immune responses in oral fluids, the research sheds light on how the virus behaves in the body and its association with symptom severity.


New study reveals oral markers may predict COVID-19 disease course

The Study: Oral Fluids and SARS-CoV-2
This Medical News report details how the team examined the relationship between the oral presence of the virus, antibodies, and symptom development. A total of 45 participants, both symptomatic and asymptomatic, were enrolled in the study. The participants provided saliva and throat wash (TW) samples, and researchers used these samples to measure SARS-CoV-2 viral load and immune responses using advanced techniques like RT-qPCR, lateral flow assay (LFA), and immunoblotting.
 
Saliva and throat wash samples were assessed for the presence of the virus and specific immune markers. While nasopharyngeal RT-qPCR has long been the gold standard for COVID-19 detection, this study explored how oral fluids could be a simpler and less invasive alternative to predict disease outcomes.
 
Key Findings: Oral Viral Persistence and Disease Severity
One of the most significant findings from the study is the persistence of the SARS-CoV-2 virus in oral fluids. The study showed that in symptomatic patients, the viral load remained detectable in oral samples for an extended period. Specifically, viral RNA and protein persisted in the throat wash of over 60% of participants at the four-week mark, while saliva samples also displayed prolonged viral presence.
 
Oral immune responses, particularly IgM antibodies, were found to be directly correlated with the severity of symptoms such as fatigue and cough. Participants who had higher levels of salivary IgM generally experienced milder symptoms, whereas lower levels of IgM were associated with more severe symptoms like nausea and weakness.
 
The research also highlighted that women, on average, had higher IgM levels in their throat wash compared to men. Although this difference did not reach statistical significance, it aligns with other studies that suggest sex-based differences in immune responses, particularly during COVID-19 infection.
 
Understanding Oral Transmission Risks
The study further underlined the importance of understanding oral transmission. Findings suggest that viral replication may be actively occurring in the oropharynx, contributing to the potential for oral transmission of SARS-CoV-2. Importantly, the researchers detected active viral replication in participants’ oral fluids through subgenomic RNA (sgRNA) testing, which is a marker of viral activity.
 
Another striking observation was the presence of viral proteins that mimic certain human host proteins. This discovery opens up questions about how SARS-CoV-2 might evade the immune system or cause complications by imitating the body's own proteins. This mimicry may also explain why some tests yielded false positives, as these proteins share structural similarities with viral proteins.
 
Exploring Salivary Antibodies
Another critical discovery was the relationship between salivary antibodies, particularly IgG, and COVID-19 symptoms. Anti-spike IgG antibodies in saliva were positively correlated with nasopharyngeal RT-qPCR positivity. In simpler terms, when a patient had detectable viral RNA in their nasopharynx, they also tended to have IgG antibodies present in their saliva. This discovery suggests that saliva could serve as an accessible and reliable biomarker for diagnosing active COVID-19 infection.
 
Interestingly, while anti-spike IgM levels in saliva indicated the presence and severity of symptoms, this pattern was not seen in the blood serum samples of the same patients. This discrepancy suggests that oral immune responses could provide a unique perspective on how the body combats the virus, particularly in the early stages of infection.
 
Sex Differences in Immune Responses
The study also examined sex differences in immune responses and symptom severity. It was found that women tend to mount a stronger oral IgM response compared to men, which may explain why women generally experience less severe outcomes from COVID-19. Higher IgM levels in women correlated with fewer symptoms and less severe disease progression.
 
This finding aligns with broader research indicating that females tend to have stronger humoral immunity, the part of the immune system responsible for antibody production. This sex-based difference could be one of the factors contributing to lower COVID-19 mortality rates in women compared to men.
 
Implications for COVID-19 Diagnosis and Transmission
The implications of this research are significant, particularly in the realm of COVID-19 diagnosis and transmission prevention. Oral samples provide a less invasive and potentially more convenient method for monitoring viral load and immune response. Additionally, the detection of prolonged viral persistence in oral fluids highlights the need for caution when considering potential oral transmission risks.
 
This study adds to the growing body of research suggesting that oral fluids, such as saliva and throat wash, could be used to predict disease outcomes and monitor the progression of COVID-19. Given the potential for oral fluids to indicate both viral presence and immune response, this research opens up new avenues for early and non-invasive COVID-19 diagnostics.
 
Conclusion: The Future of COVID-19 Monitoring
This research marks a significant step forward in understanding how oral biomarkers can predict COVID-19 disease progression. The findings show that SARS-CoV-2 viral persistence in oral fluids correlates with disease severity and immune response, particularly through salivary IgM levels. The potential for sex-based differences in oral immune responses, particularly among women, provides further insight into how the disease manifests differently across populations.
 
Oral fluids present an attractive option for ongoing COVID-19 monitoring due to their ease of collection and the wealth of information they provide about the body's response to the virus. This could be particularly important for monitoring asymptomatic individuals, who may still carry and transmit the virus without knowing it.
 
The study findings were published in the peer-reviewed journal: Scientific Reports.
https://link.springer.com/article/10.1038/s41598-024-67504-w
 
For the latest COVID-19 News, keep on logging on to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/individuals-with-long-covid-after-omicron-infection-show-altered-oral-microbiota
 
https://www.thailandmedical.news/news/ohio-case-report-shows-that-covid-19-can-also-cause-painful-oral-lesions